Virtual genetic diagnosis for familial hypercholesterolemia powered by machine learning.


Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
10 2020
Historique:
pubmed: 6 2 2020
medline: 2 10 2021
entrez: 6 2 2020
Statut: ppublish

Résumé

Familial hypercholesterolemia (FH) is the most common genetic disorder of lipid metabolism. The gold standard for FH diagnosis is genetic testing, available, however, only in selected university hospitals. Clinical scores - for example, the Dutch Lipid Score - are often employed as alternative, more accessible, albeit less accurate FH diagnostic tools. The aim of this study is to obtain a more reliable approach to FH diagnosis by a "virtual" genetic test using machine-learning approaches. We used three machine-learning algorithms (a classification tree (CT), a gradient boosting machine (GBM), a neural network (NN)) to predict the presence of FH-causative genetic mutations in two independent FH cohorts: the FH Gothenburg cohort (split into training data ( In the diagnosis of FH-causative genetic mutations, all three machine-learning approaches we have tested outperform the Dutch Lipid Score, which is the clinical standard. We expect these machine-learning algorithms to provide the tools to implement a virtual genetic test of FH. These tools might prove particularly important for lipid clinics without access to genetic testing.

Identifiants

pubmed: 32019371
doi: 10.1177/2047487319898951
doi:

Substances chimiques

Lipids 0
DNA 9007-49-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1639-1646

Commentaires et corrections

Type : CommentIn

Auteurs

Ana Pina (A)

CEDOC - Centro de Estudos de Doenças Crónicas, NOVA Medical School/Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Portugal.
Portuguese Diabetes Association, Education and Research Center (APDP-ERC), Portugal.
Department of Medical Sciences, University of Aveiro, Portugal.

Saga Helgadottir (S)

Department of Physics, University of Gothenburg, Sweden.

Rosellina Margherita Mancina (RM)

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, Wallenberg Laboratory, University of Gothenburg, Sweden.

Chiara Pavanello (C)

Centro E. Grossi Paoletti, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Italy.

Carlo Pirazzi (C)

Department of Cardiology, Sahlgrenska University Hospital, Sweden.

Tiziana Montalcini (T)

Clinical Nutrition Unit, Department of Medical and Surgical Sciences, University Magna Graecia, Italy.

Roberto Henriques (R)

NOVA Information Management School, Campus de Campolide, Portugal.

Laura Calabresi (L)

Centro E. Grossi Paoletti, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Italy.

Olov Wiklund (O)

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, Wallenberg Laboratory, University of Gothenburg, Sweden.

M Paula Macedo (MP)

CEDOC - Centro de Estudos de Doenças Crónicas, NOVA Medical School/Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Portugal.
Portuguese Diabetes Association, Education and Research Center (APDP-ERC), Portugal.
Department of Medical Sciences, University of Aveiro, Portugal.

Luca Valenti (L)

Translational Medicine, Department of Transfusion Medicine and Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Italy.

Giovanni Volpe (G)

Department of Physics, University of Gothenburg, Sweden.

Stefano Romeo (S)

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, Wallenberg Laboratory, University of Gothenburg, Sweden.
Department of Cardiology, Sahlgrenska University Hospital, Sweden.
Clinical Nutrition Unit, Department of Medical and Surgical Sciences, University Magna Graecia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH